Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Retained Earnings (2016 - 2025)

Utah Medical Products has reported Retained Earnings over the past 16 years, most recently at $128.7 million for Q4 2025.

  • Quarterly results put Retained Earnings at $128.7 million for Q4 2025, down 0.5% from a year ago — trailing twelve months through Dec 2025 was $128.7 million (down 0.5% YoY), and the annual figure for FY2025 was $128.7 million, down 0.5%.
  • Retained Earnings for Q4 2025 was $128.7 million at Utah Medical Products, up from $128.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for UTMD hit a ceiling of $139.0 million in Q1 2024 and a floor of $112.9 million in Q1 2021.
  • Median Retained Earnings over the past 5 years was $128.1 million (2025), compared with a mean of $126.6 million.
  • Biggest five-year swings in Retained Earnings: increased 10.89% in 2023 and later dropped 7.76% in 2025.
  • Utah Medical Products' Retained Earnings stood at $115.3 million in 2021, then increased by 9.27% to $126.0 million in 2022, then increased by 9.79% to $138.3 million in 2023, then decreased by 6.53% to $129.3 million in 2024, then dropped by 0.5% to $128.7 million in 2025.
  • The last three reported values for Retained Earnings were $128.7 million (Q4 2025), $128.0 million (Q3 2025), and $126.9 million (Q2 2025) per Business Quant data.